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User-centred design (UCD) is a type of user interface design in which the needs and desires of users are taken into
account at each stage of the design process for a service or product; often for software applications and websites.
Its goal is to facilitate the design of software that is both useful and easy to use. To achieve this, you must
characterise users’ requirements, design suitable interactions to meet their needs, and test your designs using
prototypes and real life scenarios.
For bioinformatics, there is little practical information available regarding how to carry out UCD in practice. To
address this we describe a complete, multi-stage UCD process used for creating a new bioinformatics resource for
integrating enzyme information, called the Enzyme Portal (http://www.ebi.ac.uk/enzymeportal). This freely-available
service mines and displays data about proteins with enzymatic activity from public repositories via a single search,
and includes biochemical reactions, biological pathways, small molecule chemistry, disease information, 3D protein
structures and relevant scientific literature.
We employed several UCD techniques, including: persona development, interviews, ‘canvas sort’ card sorting, user
workflows, usability testing and others. Our hope is that this case study will motivate the reader to apply similar
UCD approaches to their own software design for bioinformatics. Indeed, we found the benefits included more
effective decision-making for design ideas and technologies; enhanced team-working and communication; cost
effectiveness; and ultimately a service that more closely meets the needs of our target audience.
Keywords: 3D protein structure, Biological pathways, Card sorting, Design, Enzyme, Enzyme portal, Implementation,
Personae, Prototyping, User-centered design (USA spelling), User-centred design, User experience, User profiles, User
requirements, Usability testingBackground
User-centred design (UCD) is defined as “an approach
to design that grounds the process in information about
the people who will use the product. UCD processes focus
on users through the planning, design and development
of a product” [Usability Professionals Association http://
www.upa.org]. With the aims of UCD in mind, we have
designed and built a new digital portal, ‘Enzyme Portal’
to display publicly available enzyme-related information;
available at http://www.ebi.ac.uk/enzymeportal. The aim
of this freely-available service is to bring together* Correspondence: steinbeck@ebi.ac.uk
†Equal contributors
1EMBL-EBI, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SD,
UK
Full list of author information is available at the end of the article
© 2013 de Matos et al.; licensee BioMed Cent
Commons Attribution License (http://creativec
reproduction in any medium, provided the ordisparate biological and chemical data, so that all the in-
formation at a specific point in time about a given en-
zyme (or other protein with enzymatic activity, such as
receptors), can be explored in one place.
In the recent past, integration of bioinformatics data
has proven challenging due to the vast amounts available
in the public domain, and in some cases due to the lack
of agreed data-sharing standards. In spite of these hur-
dles, much has been published recently on integration
software and portals for bioinformatics applications,
often aimed at the bench scientist rather than the
informatician [1-5] (also see EBI Search, EMBL-EBI’s
gene and protein data summary service, example [6], un-
published, which is based on the EB-eye search [7]).
At EMBL-EBI we have recently moved to applying
UCD techniques to develop new software services [8]ral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
de Matos et al. BMC Bioinformatics 2013, 14:103 Page 3 of 15
http://www.biomedcentral.com/1471-2105/14/103and this article is the first full account of this type of
work for bioinformatics. We describe the methodology
applied for the design and development of the Enzyme
Portal so that others may be inspired to use the same
approaches and see the benefits of having a more useful
and usable end product.
UCD for bioinformatics in the literature
It is recognised that bioinformatics resources suffer from
significant usability problems. Javahery et al., for example,
make the point that bioinformatics interfaces “lack sophisti-
cation” compared to those that people come across in their
daily lives on other websites and in other software applica-
tions [9]. Moreover, Bolchini et al., who performed usability
inspections for four major bioinformatics web applications,
showed that users were unable to complete their tasks due
to usability problems [10]. The result is that user expecta-
tions are frequently not met when interfacing with bioinfor-
matics resources, and this influences the rate of adoption
and general use of the data and services [9]. This is un-
favourable, since the public domain has invested money in
creating these resources and data content, so the greatest
value possible should be leveraged from them if the funders
are to realise a good return on their investment. By apply-
ing proven practices in usability engineering we, as a com-
munity, have the opportunity to significantly improve the
usability, and thus utility, of bioinformatics resources. In-
deed, in Rutherford and co-workers’ article, which demon-
strated improved usability of one type of gene browser view
compared to another, they state: “it is essential that usabil-
ity issues are key design criteria for bioinformatics software
if it is to be of maximum value to researchers who are in-
creasingly reliant on it” [11].
In summary, usability is a genuine problem for bioinfor-
matics services. To address it, we believe that users should
be taken into account from inception of new bioinformatics
resources, rather than at the end when the project is
already well under development – with the caveat that
heuristic analysis of existing systems may also be helpful,
for example, when redesigning a service [12].
Challenges when applying UCD to bioinformatics
UCD is a general design philosophy, therefore should the-
oretically be applicable to any domain. For example, it has
been successfully applied to the Web for e-commerce [13],
mobile development [14] and gaming [15]. However, case
studies about how to increase usability of scientific software
are in short supply in the literature, and virtually non-
existent for bioinformatics, specifically. One example for
chemistry, [16], showed how the authors applied UCD to
design an e-science laboratory book. They observed chem-
ists in the laboratory and noted how they interacted with
their physical laboratory notebook, which then inspired the
design of a digital version.Moreover, the lack of ‘step-by-step’ information for UCD
in bioinformatics may be due to the fact that bioinformatics
is a complex data domain. Consequently, we suggest that
there is a unique combination of challenges to be overcome
when attempting to apply UCD to bioinformatics; these
include:
 ‘Dry’ (computational) and ‘wet’ (lab-based) life
science research communities often use the same
software resources, so there are challenges to meet
their diverse needs, and to account for their
different level of computer skills.
 It is difficult to measure the impact of UCD. Desired
outcomes of bioinformatics services are improved
access and understanding of the data being provided,
which in turn, may lead to more fruitful scientific
discoveries. ‘Discovery’ is an intangible metric and
therefore difficult to demonstrate to stakeholders.
 Historically, this community has not used UCD
approaches; it requires a ‘cultural shift’.
Bioinformatics applications have often been
command-line driven and technical in nature.
Moving these types of functionalities to the Web is a
new frontier, which sometimes meets resistance
when it is perceived that usability practitioners may
be ‘over-simplifying’/‘dumbing down’ interfaces.
 Biology is a complex and constantly evolving subject
where standard rules often have exceptions,
therefore interfaces to the information are difficult
to design. Take Enzyme Commission (EC)
nomenclature, for example, which is a hierarchical
structure of the data to describe enzyme function.
This is a set of rules used by some biochemists to
categorise enzymes, but it fails to separate all
enzymes effectively for other life scientists, who use
the same data resources. For instance, COX-1 and
COX-2, which have the same EC number (rule), but
have very different (scientifically and commercially
important) functions in the body. Likewise, criteria
to define a ‘small molecule’ or ‘chemical’ fail to
account for large biomolecules such as peptides
or tRNA.
 Vast amounts of interconnected data are being
generated in bioinformatics. It is a huge technical
challenge to present the data in meaningful ways to
the user. One has to consider the technical
constraints and scalability as well as what the user
wants and make compromises.
 It is difficult to find individuals with sufficient
knowledge of three discrete sciences (namely,
human-computer interaction, molecular biology/
biochemistry/bioinformatics, and computing) to
carry out UCD work effectively in bioinformatics; a
problem for many complex domains [17]. This is
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key to developing effective strategies for capturing
user requirements, designing solutions, and setting
plausible scenarios and tasks for usability testing.
To attempt to meet the above challenges, we devised a
full lifecycle of UCD techniques to design the Enzyme Por-
tal. For example, we used a bespoke variant of card sorting
(‘canvas sort’, described later) to allow prioritisation and cat-
egorisation of a large number of data items and functional-
ities, instead of applying a generic card sorting approach
(such as in [18]). Hence, we believe that this case study
may be informative for those wishing to design digital ser-
vices for the life sciences, where complex interconnected
data is involved.
Methods
A summary of our UCD approach is outlined in Figure 1.
Chilana et al. [17] have shown that effective results in a
UCD process can be achieved when user experience ana-
lysts either work closely with domain experts, or are ex-
perts in the domain themselves and have had training in
usability evaluation. For creating the Enzyme Portal, we
used the former approach, where domain experts, such as
scientists working in the field of enzymology or pharma-
ceutical research were consulted at several points in the de-
velopment process to inform the most appropriate design
and implementation of the system. There was also some
knowledge of chemistry and biochemistry amongst the de-
sign team members.Figure 1 Outline of the user-centred design process used during the
each step and the dotted lines indicate the scope of influence they had on
interactive prototype. Software implementation started once the first versio
see details in the main article.The choice, and order, of activities (Figure 1) were based
on: the nature of the data content, the availability of users,
and the information we needed at the time. UCD ap-
proaches vary and this is just one manifestation of a UCD
lifecycle. The dotted lines indicate the influence that each
step had on the project; for example, user profiles (or ‘per-
sonae’, described later) were used throughout the project,
such as for recruiting participants for workshops and us-
ability testing. Each element shown in Figure 1 corresponds
to specific pieces of work, so for a more detailed set of steps
see the full workflow in the Additional file 1.
Ethical approval from an institutional ethics board is usu-
ally necessary when conducting usability studies with par-
ticipants. Participant consent forms are often required and
may vary depending on the institution and type of study
conducted. In accordance with the EMBL ethics commit-
tee, all participants were asked to sign a consent form
(see Additional file 2) and informed of their right to with-
draw their participation at any time. Identifiable traces of
participant data were removed and no data were made
publicly available. All data handling conformed to the
EMBL-EBI Terms and Conditions (http://www.ebi.ac.uk/
about/terms-of-use).
We now give an account of each step in our UCD
process.
Stakeholder requirements were captured to define the
scope of the project
We had an initial meeting with the project stake-
holders, including UniProtKB [19], PDBe [20], ChEBIproject. The boxes indicate the approximate time taken to complete
the project. Usability testing has continued right through to the
n of the specification was available. Note: ‘personae’ are user profiles;
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specialised databases such as MACiE [23] and CoFac-
tor [24]. The two types of stakeholders were: (a) re-
searchers who aim to raise the profile of their research
output, and (b) service-providers, who already had their
own service ‘brand’ and wanted to maintain visibility of
that brand. The objective of the meeting was to capture
the requirements and set expectations for the project. It
was also explained that this process was going to adopt a
user-centred approach.
This step ensured all stakeholders had an opportunity to
contribute, and they understood the UCD process we
would adopt for the project. We agreed to hold bi-weekly
meetings to provide opportunities raise concerns.
Personae (user profiles) were created to focus design for
the users
An important tool in UCD is the ‘persona’. A persona is a
user archetype, representing a major user group, that can
help guide decisions about product features, interactionsFigure 2 Personae were developed by the stakeholders and refined b
(a) ‘Eunice’, and (b) ‘Debra’. Both represented bench scientists, with Eunice
and three others shown in the Additional files 3 (‘Eric’ and and ‘Dean’) and
users of the Enzyme Portal website. We described them in terms of name,and navigation [25,26]. Their individual attributes, features
and abilities are an amalgamation of data that is collected
as part of user research carried out early in a project. Each
persona can then be used, throughout the lifetime of a
project, as a kind of lens through which to view elements
and features of a website. For example, you can ask ques-
tions such as “How would removing feature X affect the
workflow of persona Y?” This means that you can con-
tinue to keep the user at the centre of the design process.
Furthermore, the persona is an important tool to allow
empathy with the end user, as it reminds the development
team that the user of the system has different goals
to their own. In fact, Hudson [27] describes how the
‘self-as-user’ outlook in Baron-Cohen’s Empathising-
Systemising Theory [28,29] may be mitigated by applying
personae to a software design process.
We generated ideas for thirteen initial personae with in-
put from the stakeholders. We decided to focus on just five
of these, choosing those that had distinct motivations and
behaviours, but all needing to access the Enzyme Portaly user interviews. Two examples of the personae we created are
working in enzymology, and Debra in drug discovery. These personae,
4 (‘Brenda’), reflected the expected desires and behaviours of potential
role and motivations for using an enzyme resource.
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such as programmatic access. The personae were given
names, a short description of their job role, a set of research
questions they might ask, and an image (Figure 2).
We focused on the ‘novice’ user for the first release of the
Enzyme Portal. When developing a new bioinformatics ser-
vice there is a tension between designing for the beginner
(infrequent user) versus the expert (frequent user) [9]. This
is because both bench scientists working in biological re-
search (usually ‘novice’ users) and computational scientists
working exclusively on the computer (usually ‘expert’/
‘power’ bioinformaticians) may wish to use the same bio-
informatics resource, albeit in different ways. For the En-
zyme Portal, our sights were on the former, because we felt
that the data to be presented would otherwise be very diffi-
cult to find and integrate manually, but could be easily
achieved programmatically by a user with appropriate tech-
nical skills.
Indeed, it has been shown in the qualitative study re-
ported by Javahery and co-workers [9] that novice users
rated satisfaction with bioinformatics web interfaces lo-
wer - across several usability metrics - compared to expert
bioinformaticians Hence, it can be harder to achieve a sat-
isfactory level of usability for the novice. Accordingly, the
decision to serve the infrequent user was reflected in the
five personae chosen for the UCD of the Enzyme Portal.
Interviews were carried out with users to validate the
personae
Several members of the team had relevant experience in
scientific research, hence our personae could be formulated
on the basis of this experience, however we needed to con-
firm and refine the five personae by collecting information
from the real people who represented them. To do this, we
conducted one-to-one user research interviews, using the
personae information to identify appropriate interviewees.
For ‘Eunice’, Figure 2, (a), we interviewed a principal investi-
gator at the University of Warwick. Likewise for ‘Debra’,
Figure 2 (b), we conducted an interview with a senior scien-
tist from a research-based pharmaceutical company. In this
particular discussion, it became clear that the requirements
of in vitro versus in vivo discovery scientists were distinct
and should be separated; thus our original persona (not
shown) was split into ‘Debra’ (in vitro discovery scientist,
Figure 2 (b)) and ‘Dean’ (in vivo discovery scientist, see
Additional file 3). The fifth persona -'Brenda', the bio-
marker research scientist - is in Additional file 4. The per-
sonae were edited after the interviews to reflect the ideas
and language used by the interviewees [30].
Additionally, in the interviews, we confirmed the star-
ting points and end points of a given user story, for ex-
ample: would Eunice usually use a gene name, accession
number or keyword to search the Enzyme Portal? What
data would Debra need to feel satisfied after leaving thesite? Essentially, we wanted to understand how the En-
zyme Portal might fit into the context of a larger work-
flow, so we could construct plausible user journeys.
Workflow analysis mapped out the behaviours and
context of use for the personae
To understand the flow of steps through the Enzyme Portal
website, we created a map that included all the information
from the personae and interviews in one diagram. We
started by creating a formal task analysis diagram [31], with
users on the left and the system on the right, and arrows
denoting the information flow. But this rapidly became too
complicated, and thus would be of limited value as a com-
munication tool for the team or with users. Instead, we
chose to create a workflow map (see Figure 3 for an ex-
cerpt, and Additional file 5 for the complete workflow ana-
lysis diagram).
The aim of workflow analysis was to identify key overlaps
and ‘hubs’ in the Enzyme Portal site map. For example, it
showed us that the headline/summary page was likely to be
visited by virtually all personae, so this was an important
page in the design. The major routes through the layers of
the Enzyme Portal system were also identified in this way.
Next, we refined the map by adding the findings from user
workshops conducted with enzyme research experts.
Furthermore, when prototypes of the Enzyme Portal were
ready (later in the process), the map served as a verification
tool for testing the functionality of the site. For example,
for usability testing sessions we could use the map to design
relevant scenarios and tasks.
Workshops with domain experts identified priorities for
the design and provided information architecture
The output of our workflow analysis showed that when
presented with the options, users wanted virtually all of
the data we could possibly provide. Given the large
amounts of data available in the databases for our pro-
ject (UniprotKB, Reactome, PDBe, etc.), it was going to
be a problem presenting all this data in a usable format;
thus, we needed users to prioritise the information so it
could be displayed within reasonably sized chunks that
users could interpret. We also wanted users to categorise
the information in meaningful ways: essentially to create
a basic information architecture for enzyme biology and
biochemistry. In light of this, we chose to conduct user-
focused workshops where we would:
 provide a method for our users to prioritise the data
and negotiate amongst themselves the importance
attached to each type of data, ultimately reaching
consensus.
 facilitate a discussion on how they wanted to
interact with the data, and how it would fit with
their existing research tasks.
Figure 3 Excerpt of the workflow analysis for the Enzyme Portal. The workflow is a large and comprehensive model of how the user
journeys for various personae interact with the Enzyme Portal, and serves to highlight commonalities in behaviour across personae. The thought
bubbles indicate the motivation for the user to come to the Enzyme Portal, and the arrows indicate the flow through the layers of the site. The
boxes represent individual webpages and list the data items expected to be displayed at each stage of the journey. The complete workflow is
available in the Additional file 5.
de Matos et al. BMC Bioinformatics 2013, 14:103 Page 7 of 15
http://www.biomedcentral.com/1471-2105/14/103 confirm and refine the information we had collated
from user interviews, and the user workflows. For
example, one participant suggested an entry point to
the Enzyme Portal should be via a scientific paper,
not just via an enzyme name - this was an addition
to the workflow for the ‘Eunice’ persona.
We carried out two workshops: one at EMBL-EBI with
ten experts from academia and a pharmaceutical research
and development (R&D) organisation; and another at an
agrichemical company R&D site with six plant researchers
and bioinformaticians. The participants were recruited
based on their similarity to the personae, and included prin-
cipal investigators, researchers and PhD students.
We prepared activities to elicit feedback from the partici-
pants. For example, to address the issue of data prioritisa-
tion we came up with a new variant of a card sorting
exercise called, ‘canvas sort’ (Figure 4). The standard way to
perform card sorting for web design involves participantsputting item cards, which represent information on a web-
site, into separate piles and giving each pile a group name.
In an open sort they write their own names, whereas in a
closed sort they use pre-labelled group cards [18]. This
method gives a picture of the users’ mental model of
the items.
In contrast, our method required that users select the
most valuable data items for their research, and arrange
them in a structured fashion on canvas template, see
Table 1. The data items are listed in the Additional file 6;
they included data items such as “enzyme reaction”, “en-
zyme mechanism” and “chemical compound/ligand”. The
specific components users had to place onto the canvas in-
cluded data items (nouns) and interactive elements (verbs),
see Table 2. We carried out a pilot study with the project
stakeholders to ensure the canvas sort method was effective
before using it in the workshops.
Canvas sorting was carried out in groups of three or
four participants. We avoided power relationships in a
Figure 4 Photograph of the materials used in the canvas sort
activity with user workshop participants. A novel ‘canvas sort’
approach was used in workshops with users to elicit information
architecture, and to prioritise enzyme-related data items.
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their supervisors, and where possible, we avoided group-
ing people from the same organisation together. We also
had a mix of user profiles represented in each group to
try and achieve consensus.
The agenda included an ‘ice breaker’ activity to increase
familiarity between the members of each team. The rules of
the canvas sort activity were explained using a non-
scientific example, in this case a retail website for books.
The activity was split into three parts: 40 minutes for the
activity, ten minutes for each team to report back their
findings, and a few minutes for discussion with the other
teams; thus it followed Gray et al.’s suggested ‘opening’ (set-
ting the rules), ‘exploring the world’ (playing the game) and
‘closing’ (presenting back) of creative ‘game-storming’ tech-
niques for team-based workshops [32]. We video-recorded
the reporting back sections. Each group also had a facilita-
tor to stimulate and record discussion amongst the team
members.Table 1 The structure of the canvas used in the canvas
sort activity during user workshops
Canvas name Actions
Data card selection
How to get here? Where to go next?
The canvas sort activity was divided into four main sections one for data cards
and the other sections were used to describe the interaction on those
data cards.Analysis of the workshop findings informed design
decisions
After the workshops, we photographed the canvasses; see
Figure 5 for an example. Using these artefacts and the vid-
eos, we manually noted the specific data items, actions and
navigation for each canvas and grouped canvasses with
similar-sounding names across groups (Table 3). For de-
signing the Enzyme Portal interfaces, we prioritised data
items, functionality and navigation that co-occurred in
these findings.
The canvas names and details formed the backbone of
the design for the website’s navigation. Using the find-
ings, we were able to abstract an information architec-
ture for enzyme biology relevant for the Enzyme Portal
(Figure 6). It illustrates the major connections between
protein, reaction, pathways and small molecules from
the users’ perspective.
Paper prototypes made it easy to share ideas for the
design
We created paper prototypes (static images) for the En-
zyme Portal and used the information from earlier user
research, such as the interviews and workshops, to guide
the visual designs. Paper prototypes are simple represen-
tations of a user interface in different states, and allow
rapid, iterative design of pages and their transitions [33].
Often they are simply sketches or printouts of interfaces
that are used in the early stages of development to try
out ideas quickly [34,35]. Although they lack the
complete functionality, sketches can be used to test users’
interactions with a proposed interface as they contain
real data examples.
We ensured that the functionalities requested by
users were included in our prototype designs. We
used paper and pencil to sketch ideas individually and
we discussed each design idea as a group. Good ideas
were incorporated into a set of paper prototypes
using the Balsamiq (http://www.balsamiq.com) toolkit,
see Additional file 7.
Paper prototype usability testing highlighted problems
with the design
Paper prototype testing is beneficial because the over-
head of design is low, since time is not invested produ-
cing high-fidelity prototypes. When testing them with
users, participants are free to concentrate on exploring
features, without the distraction of high-fidelity designs,
interactions and colours. We could also test them with
users at a very early stage. Moreover, because the
prototypes were on paper, they could be rapidly
redrawn and redesigned when usability issues
emerged during testing.
In a paper prototyping experiment, test participants are
briefed about what to expect in the testing, and its
Table 2 Summary of the components of the canvas sort activity
Component added
by the users to the
canvas
Description of the component UCD information and useful outputs from the component
Canvas name Users were required to select the name of the canvas and to
choose data cards to put onto the canvas.
Category names, in the users own words, were useful for the
site map, information architecture and for understanding the
overarching concepts that were important to the users.
Data card selection Data cards were based on data items extracted from our
existing resources and also requests during the interview
process such as “enzyme reaction”, “enzyme mechanism” and
“chemical compound/ligand”. These were printed in duplicate
onto white card and cut out to any reasonable size. Blank
cards were also available so users could create their own data
items if none of the available were appropriate. After selecting
a number of data items users had to democratically vote to
keep only six using the dot voting method [as described in
[29]).
This was the prioritisation task of the exercise. By allowing
only 6 items to be collated on one canvas, it forced
participants to prioritise which were most valuable to them.
An incidental benefit of this approach was that users’
awareness was raised, regarding the data items we could
provide via EMBL-EBI public data resources.
Actions On sticky notes users had to describe what actions they
wanted to perform on these data items.
Nouns (data items) and verbs (actions) needed to be captured
in the workshop in order to translate them into specifications
for the Enzyme Portal design.
How to get there? Describe how they could navigate to this canvas. This gave insight into the navigational structure that users
required.
Where to go next? Describe where they would want to get after this canvas. This gave insight into the navigational structure that users
were after.
The main purpose of the canvas was to identify what data was valuable to users at each point of the workflow and how users wanted to interact with the data.
The workflow was also captured by the final two sections, which describe how users got to this canvas and where they would like to go next.
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prototype interfaces on paper, and are requested to talk
out loud while they do this [33]. If a participant clicks on
a button with their pen, for example, then the paper
prototype they see is exchanged for another that displays
what would be shown on screen as a result (Figure 7).
We observed participants’ reactions to the proposed fea-
tures and for transitions from one state of the interface toFigure 5 Photograph of a completed artefact generated in the canva
useful for prioritisation of data items and functionalities when planning the
produced 3 or 4 of these in the workshops.another; for example we could observe users checking the
faceted search results to filter the results set. We chose
cGMP-specific 3’,5’-cyclic phosphodiesterase (PDE5A) en-
zyme and its inhibitor, the drug Sildenafil, as the example
data for the testing sessions and for the scenario and tasks
for user testing (see Additional file 8). We chose PDE5A
because: a) this enzyme was well characterised having data
available across several biological and chemical databasess sort activity by user workshop participants. These artefacts were
structure of the Enzyme Portal. There were five teams and each team
Table 3 A portion of the matrix of commonalities for the reaction canvas in the canvas sort user workshop activity
Data items Group 1 Group 2 Group 3
Overall reaction ✓
Postulated mechanisms ✓
Evidence of mechanism ✓
Kinetic constants for various steps in the mechanism (organism and substrate specific) ✓ ✓ ✓
Reaction in pathway ✓
Enzyme inhibitors / activators ✓
Literature information i.e. original paper and most recent work on the enzyme ✓
Bioactivity data ✓
Chemical group information (classification) ✓
Chemical compound information (structure, formula, etc.) ✓
Compound supplier information ✓
Safety information on this compound ✓
This canvas illustrates the commonalities of the selection of data items by workshop participants. In this case only three groups agreed on a reaction canvas.
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was cited as a relevant example by a user in the interviews
conducted earlier in the process.
We carried out testing with four participants, who were
recruited via email to a UK University. We felt that this
relatively small number was acceptable, since only five or
six users per evaluation results in most usability issues
being identified [36]. Participants had a variety of back-
grounds including medicine and computer science. Our
aim was to determine if the flow of steps through the ser-
vice seemed intuitive for a new user. The test involved: aFigure 6 Concept diagram of the information architecture applied in
has a number of data items valuable to the user. Categories and data obje
were disease and literature, which span across all the data objects and catemoderator, who prompted the user; an observer, who took
notes; and a developer, who passed the papers representing
screens to the moderator. A rehearsal was performed to en-
sure that the task we had designed would elicit suitable
interactivity in the time available. We used a quiet room,
obtained consent, and gave participants opportunity to talk
about their own research to put them at ease. We explained
that our goal was not to test their skills, but rather the cap-
abilities of the interface.
Directly after the sessions, we collated our findings and
ordered them by priority, based on the number of times athe Enzyme Portal. The data objects are grouped and each category
cts are then interconnected. Concepts that did not fit into this model
gories.
Figure 7 The paper prototyping method was used for usability
testing of initial designs for the Enzyme Portal. The user was
presented with a paper wireframe of each screen interface and
could interact with it using a pencil instead of a mouse and
keyboard. Each screen would then change according to the
interaction. The wireframe interface designs were created using
Balsamiq software (http://balsamiq.com).
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footage, and used it as a communication tool with the team.
Some design problems became apparent immediately and
could be solved easily, such as the size of the main search
box on the homepage. But others were harder to fix, such
as the elements to display in the post-search results list.
A technical specification was written for software
development
The specification document included visual design layouts
based on the prototypes we had refined post user-testing.
The advantage of having detailed specifications at this point
was that there was less ambiguity, so it was easier for the
software development team to follow and produce a system
that faithfully reflected the requirements from users.
With well-tested specifications the team could carry out
the implementation without interruptions due to require-
ment changes, which can often occur with other methods
of software development. Moreover, the developers could
focus on the main technical challenges of data integration,
such as where performance had to be considered when data
is retrieved from disparate databases via queries to differentWeb service interfaces. Several technical solutions were
discussed among the stakeholders to overcome these type
of challenges. Performance issues were solved by applying
appropriate methods of querying the data, which were sug-
gested by the data providers themselves. Furthermore,
performance was enhanced by applying a concurrent pro-
gramming technique, where several queries are performed
simultaneously. The adapter design pattern was applied to
combine data from several interfaces into a single interface
to facilitate the queries. The implementation was concluded
successfully, with the first version of the interactive proto-
type released for testing. It is a Web application built on
the Java platform (http://www.oracle.com) and Web tech-
nologies such as Spring MVC (http://www.springsource.
org/), jQuery UI (http://jqueryui.com), HTML and CSS
(http://www.w3.org). External interfaces from which data is
queried include Distributed Annotation System (DAS) [37],
BioMart (http://www.biomart.org/) and the data providers’
propriety interfaces.
Designs were further refined after usability testing of an
interactive prototype
For usability testing of the interactive prototype, we
recruited five participants from R&D organisations in the
pharmaceutical, chemical and agri-chemical industries.
The interactive prototype was tested using MAC OS and
a Windows 7 platform, depending on participant prefer-
ence. An observer and moderator were present and the
sessions were screen recorded using Silverback Software
(http://silverbackapp.com/) and BB Flashback Express
(http://www.bbsoftware.co.uk/BBFlashBackExpress/Home.
aspx), respectively. Consent was obtained.
We summarised the key findings and discussed them
with stakeholders. The system was refined based on these
findings; for example: the location of the list of species
available for each enzyme ‘hit’ was rearranged, because
users could not locate them. Figure 8 illustrates the first
interactive prototype, which had the species on the search
results page on the right-hand side of the box in the search
results hit list (highlighted in red). Usability testing
highlighted that users did not see this information on the
left-hand side either. The solution was to move the species
list below the function and synonyms section (Figure 9)
(highlighted in red).
Results
Historically, enzyme information at the European Bioinfor-
matics Institute website was organised across multiple data
resources, which were loosely hyperlinked. Initial interviews
indicated that users struggled to identify which resources
were available, and could not navigate the information, as it
was not logically grouped together and was not easily
searchable. Users also pointed out that critical information
was missing (e.g. disease). The Enzyme Portal addresses
Figure 8 The first version of the search results page using an interactive prototype. In this version not all the protein structures were
displayed and also the species were located on the right hand side of each entry found.
Figure 9 A later version of the search results page after improvements highlighted during interactive usability testing. In this version
the species are located below the synonyms, and protein structures is displayed for an entry irrespective of the default species.
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including a protein knowledgebase [19], various other
biological and chemical databases [20-24,38,39], experimen-
tal factor ontology (EFO) [40] and literature citations
(www.ebi.ac.uk/citexplore), may all be explored in a single
visual display after a single search.
Summary of insights uncovered through UCD
Specific user expectations were revealed as a direct re-
sult of applying UCD techniques to develop the Enzyme
Portal. We do not report all of the learnings we gained
from interaction with users here, however a summary of
key findings that inspired the design is below. Note that
these observations were applicable to the personae we
were designing for.
 Users do not want enzymes grouped by EC number
alone, they also require an ontology that fits with a
pharmacologically-relevant schema.
 Users want entries to be species-specific, not an
average combined model of a structure across the
protein found in several species.
 Users want to compare the list of characteristics of
two or more enzymes on the same page, as one
might compare specifications of retail products side-
by-side on a commercial website.
 The enzyme function is really important and is a key
decision maker on whether to take a deeper look at
the enzyme.
 Users want the information embedded not
hyperlinked, to save time clicking to and from
multiple webpages/ browser tabs.
 Protein structure is essential information when
looking at an enzyme. Thus, presenting
thumbnails to indicate whether a structure is
available is handy for determining which enzymes
to explore further.
 All enzyme synonyms should be searched on, not
only those approved by the NC-IUBMB. This is
because enzymes may have been referred to by
different names in the literature, so the scope of the
search must include these alternatives
 Users want to forward information to colleagues
easily and also download time-stamped data for
further reference.
 Facets are desirable for narrowing down the search
results based on the user’s criteria, such as species.
 Information about disease is under represented in
most publicly-available databases. Users want this
information categorised separately.
 In the canvas sort activity, users categorised
information in the following key categories: small
molecules, reactions, pathways, protein structure
and enzyme summary.Enzyme portal is a freely-available service hosted at
EMBL-EBI
The Enzyme Portal was released in February 2012 (http://
www.ebi.ac.uk/enzymeportal), with subsequent releases
planned for the short term to address outstanding function-
alities identified in our UCD process. Interactive prototype
testing conducted a month prior to release indicated that
users liked the features the Enzyme Portal has delivered.
The layout and categorisation of the data has also been well
received. As mentioned, minor issues were uncovered in
navigation, such as how the available species information
was displayed for each search hit (as shown in Figure 8
and 9), and these were fixed for the final release.
There are still outstanding technical and data issues that
prevent the Enzyme Portal from delivering all aspects of
the user requirements we discovered. For example, we did
not include the side-by-side enzyme comparison tool, and
the species search facets in a separate pop up window, in
the first release. We intend to resolve these omissions in
subsequent versions of the Enzyme Portal. Further user
testing has not been conducted since the release, and al-
though the portal is in its infancy informal interviews with
users who have been introduced to the portal through the
EBI’s training programme have heralded it a success.
We see UCD as an overarching philosophy, and thus
we plan to continue monitoring user interactions with
our new service going forward; for example, through
website usage analysis and continued usability testing of
software updates.
Discussion
Did the UCD approach work?
We have applied UCD thinking to the design and develop-
ment of a new bioinformatics service called the Enzyme
Portal. Many new bioinformatics services and data integra-
tion portals are described in the literature, such as those
published each year in the database issue of Nucleic Acids
Research journal [41], however few have undertaken a
UCD approach to develop them as we present here. Fur-
thermore, we believe there is a need to increase visibility of
UCD approaches in the community at large, as Veretnik
et al. suggest: “The issue of persistence and usability. . .plays
a significant role in how our discipline is perceived” and
“there are scientists themselves who publish the work but do
not want to go to the trouble of making the resources easy to
use. . .Wouldn’t it seem that evidence of usability. . .should
be prerequisite to publishing a paper . . .about such a re-
source?” [42].
Our motivation for applying UCD to the Enzyme Portal
was to create a service based on the expectations of our
users, rather than on our underlying data structure and our
own assumptions of what users would want. We have
shown how a UCD philosophy may be applied in bioinfor-
matics and provide materials for general use by developers
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plate, an example of a consent form, etc.. In summary, we
presented the practical steps involved to realistically achieve
improvements in usability: from stakeholder analysis, user
research and persona development to prototyping and us-
ability testing.
We found that the UCD process is more complex than
the traditional ‘waterfall’ software development cycle [43]
applied to the development of most new bioinformatics
services. However it offered distinct advantages to the trad-
itional methods of development. For example, the decision-
making process was simpler at each stage of the design,
because we had clear requirements from users to follow.
Furthermore, using this approach we had physical artefacts
from workshops and visual sketches as communication
tools to explain what was needed within the team. These
were helpful for preparing both visual and functional speci-
fications for implementing the software.
Other benefits of the UCD methodology included access
for the development team to feedback from users immedi-
ately after each section was implemented, rather than
receiving comments after all development was completed,
when the site could not be easily changed; as often happens
in bioinformatics software development. Another real,
yet intangible, benefit was the opportunity that UCD
provided for enhanced team-working, where developers,
stakeholders, user experience practitioners and project
coordinators were all practically involved, including for pre-
implementation activities, such as persona development,
user testing and sketching designs.
Most importantly the UCD process prevented us from
pursuing false avenues and challenged our assumptions
about the data we were integrating and displaying: for ex-
ample, in our decision not to focus on enzyme commission
(EC) numbers [44], but rather on other hierarchies, such as
ChEMBL enzyme bioactivity classification. Overall, we be-
lieve it allowed us to deliver a better experience for the end
user, compared to using a standard waterfall software devel-
opment process.
There were some limitations to the UCD process we ap-
plied; for example, software development was initially de-
layed while we were characterising the needs of our users,
hence no measurable output could be provided up-front.
However, once development did start, developers reported
that they enjoyed coding the project, and felt they were
coding efficiently because they had a clearer visual specifi-
cation to work from.
Initially, there were problems in convincing the team,
stakeholders and management of the benefits in adopting
the UCD process. This was primarily because there was an
initial cost for gathering requirements, but in the long term
this was negated by the faster development time.
Demonstrating the advantages of UCD was challenging,
because the benefits are only realised after the software isreleased, and even then, they may be intangible - such as
impacting on early-stage scientific discoveries and basic
research – thus are hard to quantify and communicate to
stakeholders. However, the intangible nature of the ‘value’
of such services is the same for most bioinformatics
services.
Conclusions
We hope that the approach used to design the Enzyme Por-
tal will motivate the reader to apply UCD to their own bio-
informatics tools and services, because we believe that if
you design a product in consultation with the user, you will
likely find that more people will use it and will benefit from
your offering - even if these benefits may be hard to meas-
ure. For the bioinformatics community, getting the design
right is key, in order that the scientific community may
reap the benefits of the public spend to create data from
scientific endeavour. It is our duty to make the data avail-
able so scientists can find and manipulate it easily. We be-
lieve UCD may provide a way to achieve this ambition in
the future.
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